1/11
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
antibiotic resistance
the ability of bacteria to withstand the effects of antibiotics, making them ineffective in treating infections; more antibiotics are needed to treat infections than before, so the dosage given is increased
is a “gradient”; i.e. pre-antibiotic resistance 1-2 would result in death of the bacteria, not 7-8 is needed. if at a 10 w/out effect, there is full resistance
full resistance
when a bacteria is unaffected by an antibiotics, even when the dosage is increased; a “cocktail” of antibiotics or more than one antibiotic are given to treat disease
examples of antibiotic resistance in Staphylococcus aureus
VISA - strain that is slightly resistant to vancomyosin
VRSA - strain that is fully resistant of vancomyosin
the more —- of antibiotics the —- antibiotics resistance will continue to grow
usage, more
How is there an evolutionary basis to antibiotic resistance
most antibiotics are derived from the soil (streptomyces) and release antibiotics to kill of or inhibit competing microorganisms to get more nutrients to grow. -→ bacteria also has evolutionary drive, so coevolution occurs
bacteria and antibiotics are evolving together, and using one another as “inspiration” on how to evolve and better compete
as a result, bacteria has survived pressure in an environment and why we’re entering the end of the age of antibiotics
efflux pumps
strategy of bacteria to counteract antibiotics
will pump out antibiotics from the cells
antibiotics will not be effective because the antibiotics are not inside of the bacterial cell
use energy from ATP
biofilm
strategy of bacteria to counteract antibiotics
film the forms and protects the “bottom” layer of bacteria from antibiotics due to the top layer acting as a cushion → as a result, it is difficult for antibiotics to reach the bottom levels
ex: pseudpmonas aeruginosa (water borne bacteria) and cystic fibrosis (occurs when the protein channel mutates so mucous is unable to receive ions and becomes thick, allowing bacteria to get trapped)
P. aeru can form in the mucous of those with c. fibrosis and form biofilms
overproduction of targets in bacterial cells
bacteria will produce more of the cellular components that are being targeted by the antibiotic
method of bacteria to counteract antibiotics
ex: if you have 50 bullets and must hit 2-3 targets, you have a higher chance of landing some bullets. if you have 50 bullets but 3000 targets, theres no way of hitting every single one
bullets are the antibiotics and the targets are bacterial cells
explains why increasing the dosage can be effective
produce enzymes that target antibiotics
the bacteria will produce specific enzymes that breakup the specific structure of the antibiotic so that it is ineffective; method of bacteria to counteract antibiotics
ex: Beta lactamase - enzyme made by bacteria (common in S. aureus); will break up the rings (chemical makeup) of the Beta lactum structure (antibiotic)
the enzyme produced by the bacteria must correspond with the antibiotic structure (ex: an enzyme that breaks up the structure of beta lactums would not be able to breakup the structure of vancomyosin)
inhibitors are added to antibiotics as supplements to prevent the bacterial enzyme from working
Beta lactamase inhibitors
sylvanic acid that is added as a supplement to antibiotics to inhibit Beta lactamase and prevent it from breaking apart the structure of antibiotics
ex: MRSA - methicillin resistant s. Aureus → modified antibiotics so that the antibiotic is not being effected by the enzyme produced by A. aureus
Augmentin - mix of amoxicillin and sylvanic acid
Modify the target
method of bacteria to counteract antibiotics
ex: vancomyosin targets the alanine-alanine cross bridges of bacteria; bacteria modifies the target (the cell wall), by changing one of the alanines to another base, so that the antibiotic is rendered useless
Modify the pathway
method of bacteria to counteract antibiotics
ex: sulfa drugs; sulfa drugs prevent the bacteria from making folic acid, which makes nucleic acids; the bacteria could change its pathway so that it would be able to make nucleic acid bases from something other than folic acid